• Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
Economy

HHS slams ‘under-tested’ mRNA technology as Trump cuts Moderna’s vaccine funding

by May 29, 2025
by May 29, 2025

President Donald Trump’s Department of Health and Human Services (HHS) is terminating awards totaling more than $750 million dollars that were provided to pharmaceutical manufacturer Moderna to help facilitate its production of mRNA-based bird flu vaccines. 

During President Joe Biden’s final week in office, his administration awarded $590 million to Moderna to help speed up its production of mRNA-based vaccines. The $590 million award followed a separate $176 million award Biden gave to Moderna earlier last year for mRNA vaccine technology.

Messenger RNA vaccines are a newer type of vaccine technology, which was utilized by companies like Moderna and Pfizer to develop their COVID-19 vaccines. The vaccine technology was at the center of a lot of criticism amid the coronavirus pandemic for potentially being associated with adverse side effects in some people who took them, such as myocarditis.

Trump administration officials previously hinted at the potential that this funding could be terminated, citing a lack of oversight during the Biden administration pertaining to vaccine production. 

‘After a rigorous review, we concluded that continued investment in Moderna’s H5N1 mRNA vaccine was not scientifically or ethically justifiable,’ HHS Communications Director Andrew Nixon said. ‘This is not simply about efficacy — it’s about safety, integrity, and trust. The reality is that mRNA technology remains under-tested, and we are not going to spend taxpayer dollars repeating the mistakes of the last administration, which concealed legitimate safety concerns from the public.’

The announcement reflects a larger shift in federal vaccine priorities, after HHS Secretary Robert F. Kennedy Jr. announced earlier this week that COVID-19 vaccines would be removed from the federal government’s list of recommended vaccines for children and pregnant women. 

Meanwhile, a report from Senate Republicans released earlier this month suggested the Biden administration withheld critical safety data and downplayed known risks tied to the mRNA COVID-19 vaccine. In particular, the Senate report focuses on HHS’ awareness of, and response to, cases of myocarditis — a type of heart inflammation — following COVID-19 vaccination.

‘Rather than provide the public and health care providers with immediate and transparent information regarding the risk of myocarditis following mRNA COVID-19 vaccination, the Biden administration waited until late June 2021 to announce changes to the labels for the Moderna and Pfizer COVID-19 vaccines based on the ‘suggested increased risks’ of myocarditis and pericarditis,’ the Senate report states. ‘Even though CDC and FDA officials were well aware of the risk of myocarditis following COVID-19 vaccination, the Biden administration opted to withhold issuing a formal warning to the public for months about the safety concerns, jeopardizing the health of young Americans.’

In response to the Trump administration’s funding termination, Moderna put out a press release acknowledging the move, but also touting the ‘safety profile’ observed amid its work on a new mRNA bird flu vaccine.

‘While the termination of funding from HHS adds uncertainty, we are pleased by the robust immune response and safety profile observed in this interim analysis of the Phase 1/2 study of our H5 avian flu vaccine and we will explore alternative paths forward for the program,’ said Stéphane Bancel, Chief Executive Officer of Moderna. ‘These clinical data in pandemic influenza underscore the critical role mRNA technology has played as a countermeasure to emerging health threats.’

Fox News Digital’s Brooke Singman contributed to this report.

This post appeared first on FOX NEWS

0 comment
0
FacebookTwitterPinterestEmail

previous post
How Interest Rates Set Asset Prices: One Weird Trick
next post
Musk officially steps down from DOGE after wrapping work streamlining government

Related Posts

Cracker Barrel CEO serves up leftover corporate branding...

August 24, 2025

The history of how Trump and Bolton’s relationship...

August 24, 2025

FBI raid of John Bolton’s home reportedly linked...

August 24, 2025

GOP senators push for Kamala Harris’ testimony as...

August 24, 2025

Justice Jackson accuses Supreme Court of ensuring Trump...

August 23, 2025

James Comer praises Kash Patel for ‘holding deep...

August 23, 2025

John Bolton blasted by Trump ally Roger Stone,...

August 23, 2025

Trump DOJ releases ‘thousands’ of Epstein files to...

August 23, 2025

Trump–Bolton feud back in focus after FBI raid:...

August 23, 2025

Jackson scathing dissent levels partisan charge at colleagues...

August 23, 2025

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent Posts

  • Foxconn recalls more Chinese engineers from India in setback to Apple: report

    August 24, 2025
  • Bank of America identifies 5 stocks with strong growth potential

    August 24, 2025
  • Cracker Barrel stock: why going back to the old logo just isn’t an option

    August 24, 2025
  • Top 3 stocks to buy with strong cash flow and sizable buyback programme

    August 24, 2025
  • Here’s the only FTSE 100 stock in Warren Buffett’s portfolio

    August 24, 2025
  • US government’s investment in Intel may not be enough for turnaround: here’s why

    August 24, 2025

Editors’ Picks

  • 1

    Meta executives eligible for 200% salary bonus under new pay structure

    February 21, 2025
  • 2

    Walmart earnings preview: What to expect before Thursday’s opening bell

    February 20, 2025
  • 3

    New FBI leader Kash Patel tapped to run ATF as acting director

    February 23, 2025
  • 4

    Anthropic’s newly released Claude 3.7 Sonnet can ‘think’ as long as the user wants before giving an answer

    February 25, 2025
  • 5

    Nvidia’s investment in SoundHound wasn’t all that significant after all

    March 1, 2025
  • 6

    Cramer reveals a sub-sector of technology that can withstand Trump tariffs

    March 1, 2025
  • 7

    Elon Musk says federal employees must fill out productivity reports or resign

    February 23, 2025

Categories

  • Economy (2,299)
  • Editor's Pick (217)
  • Investing (185)
  • Stock (1,561)
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Read alsox

The Spiritual Battle Between Communism and Capitalism

June 5, 2025

‘Not going away’: Inside the Epstein drama...

July 23, 2025

Hands Off the University, Indeed

April 18, 2025